Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 4 Mean inhibition of monocyte cyclooxygenase-2 activity ex vivo, as assessed by measurement of whole-blood lipopolysaccharide (LPS)-induced prostaglandin (PG)E2 levels in subjects taking low-dose aspirin alone (100 mg daily) for 6 days (hatched bars) and then readministered with naproxen (500 mg twice daily, with the first dose administered 2 h after aspirin) for a further 6 days (open bars). The solid bars show the effect of the same medications, administered in reversed order for further six days after a washout period of 14 days, on monocyte cyclooxygenase-2 activity. The values are reported as mean ± SEM of inhibition (%) of LPS-induced PGE2 levels caused by the different treatments, n = 4. *p < 0.05, **p < 0.01 versus pre-drug values. All times are hours after the administration of the first study drug. Open bars = aspirin before naproxen (twice daily); solid bars = naproxen (twice daily) before aspirin; hatched bars = aspirin.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement